Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

Could a "universal vaccine" protect us from future virus outbreaks? 🦠 A Cambridge team has developed an entirely new way of making vaccines. Using data from virus surveillance programmes around the world, they used AI to design a ‘super antigen’. This can create a single vaccine that provides lasting...

20,979 Aufrufe • vor 2 Monaten •via X (Twitter)

0 Kommentare

Keine Kommentare verfügbar

Kommentare vom Original-Post werden hier angezeigt

Ähnliche Videos

The COVID Vaccine That Could Have Ended the Pandemic—And Stopped a Looming "Pandemic of Cancer." The FDA Blocked It. In a stunning account, Dr. Patrick Soon-Shiong reveals the story of the vaccine that was—a true sterilizing shot designed not just to reduce symptoms, but to eliminate the COVID-19 virus from the body entirely. While "Operation Warp Speed" championed antibody-based vaccines, Dr. Soon-Shiong's "BioStrike/BioShield" took a different path. It was engineered to activate T-cells and Natural Killer cells—the body's elite forces for hunting and destroying viruses. His vaccine was the only candidate in a key primate trial that successfully cleared the virus. It promised not just temporary protection, but long-term immunity that could prevent transmission and stop the virus in its tracks. Yet, when he applied to the FDA for a Phase II trial to deploy it as a crucial booster, he was met with a wall of silence and refusal. At the same time, the manufacturing ecosystem was entirely consumed by the major players, leaving no resources for this superior alternative. Dr. Soon-Shiong issues a dire warning rooted in science: COVID-19 is a systemic vascular virus. When it lingers, it causes chronic inflammation. This inflammation, he states, has a "sad, sad chance" of triggering a looming global pandemic of cancer with a 5-10 year latency. The world was given a tool to reduce immediate mortality. But it was denied the tool that could have cleared the virus, potentially prevented long COVID, and averted a future cancer crisis. This is not just a story of a missed opportunity; it's a warning we must now heed.

Camus

300,407 Aufrufe • vor 10 Monaten

Hepatitis B is a tiny virus with just 4 genes. But it kills hundreds of thousands globally per year, mostly by infecting babies and causing liver disease or cancer over the following decades. In a new episode of HARD DRUGS, we tell the story of the hepatitis B vaccine, which became the first of many milestones: It was the first viral protein subunit vaccine, the first recombinant vaccine, and the first vaccine to prevent a type of cancer. Key stats: • Hepatitis B virus has just 4 genes, some of which overlap, making it one of the most genetically compact human pathogens • It has a very unusual life cycle for a DNA virus: it forms a stable mini-chromosome (cccDNA) inside liver cell nuclei, and uses reverse transcription, similar to HIV. • It integrates itself into your liver cells' DNA, causes repeated cycles of cell damage and repair, and inflammation that eventually leads to cancer. • During infection, the virus produces ~500 quadrillion (5 x 10¹⁷) copies of its surface antigen in the bloodstream. They act as decoys, soaking up our antibodies and helping the virus evade immunity, and it sticks around in our cells for decades. Over time, it causes one of the most common and deadliest liver diseases and cancers: ~300 million people worldwide are living with chronic hepatitis B ~600,000 people die from hepatitis B each year, mostly from cirrhosis and liver cancer While only ~5–10% of adults infected develop chronic infection, ~90% of infants infected at birth do. Around a third of those infants will eventually die from liver failure, cirrhosis, or liver cancer. But there's a vaccine against it: the hepatitis B vaccine. It is so efficient that it helps us block the virus by training us to recognize just one protein (the surface antigen) quickly, before it can overwhelm us. The first hepatitis B vaccine (1981) was made from human plasma, through multiple brutal inactivation steps that kill other microbes and contaminants. The second hepatitis B vaccine (1986) was the first recombinant DNA vaccine ever, made by factories of yeast cells churning out the antigen in bulk. The payoff has been enormous. Large cluster randomized trials have shown that hepatitis B vaccination reduces liver cancer rates by 85% and deaths by 70%. Universal vaccination of newborns has led to massive drops in hepatitis cases, liver failure, and liver cancer in younger generations. As the first viral protein subunit vaccine, it was built upon a series of breakthroughs in immunology, advances in virology and vaccinology. In this episode, we trace the discovery of hepatitis, hepatitis B virus, the development of vaccines, and their impact. And we explore how we even got to subunit vaccines at all: the great battle of immunology, the discovery of antibodies and their incredible diversity, and how that understanding could be used to test, study, and build better vaccines. If you want to understand how modern vaccines actually came to be, or why hepatitis B vaccination still matters today, this one’s for you. Timestamps: 0:00:00 Introducing the hepatitis B vaccine 0:15:46 The mysterious trail of jaundice outbreaks and the search for an invisible liver pathogen 0:28:03 How a tiny virus causes cirrhosis and liver cancer, and the struggle to identify it 0:53:19 How Maurice Hilleman developed the safest, purest vaccine in history 1:17:36 Turning the hep B vaccine recombinant 1:29:14 The impact of hep B vaccination 1:39:27 How we got here: the 19th century battle for the soul of immunology 2:01:34 How the body builds an infinite library of defenses 2:19:25 Why scientists thought immunology was solved in the 1960s 2:30:57 How better immunology led to precise subunit vaccines 2:45:33 Conclusion

Saloni

32,424 Aufrufe • vor 7 Monaten

RFK Jr. on Pfizer Trial: 23% Higher Death Rate in Vax Group Debunks "100% Effective" Myth In a stunning exposé, RFK Jr. dismantles the narrative by highlighting the shocking results of the original Pfizer trial: a 23% higher all-cause mortality rate in the vaccinated group versus the placebo group after six months. This alarming fact from the Pfizer's own clinical trial underpins what he calls the "data chaos" of the initial rollout. He eviscerates the famed "100% effective" claim that emerged from that same trial, revealing it was built on a dataset of just three COVID deaths total—two in the placebo group and one in the vaccinated group. This statistically fragile result was disingenuously spun into a universal promise of complete protection. Kennedy breaks down the brutal math from the trial data: to prevent a single COVID death, nearly 20,000 people had to be vaccinated. He argues that with the vaccine itself showing a higher mortality risk, this minuscule benefit would be instantly canceled out, potentially making the intervention net harmful. This history makes the current shift so critical. Kennedy outlines the new FDA-approved vaccine’s stark reality: it is primarily for those 65+ or with profound comorbidities under a unique and telling agreement—every recipient becomes part of an actual clinical trial. After years of mandates and declarations of "safe and effective" without robust long-term data, this new policy is a quiet admission. They are finally conducting the trial that should have been done first, using the public as participants.

Camus

127,530 Aufrufe • vor 10 Monaten

A stunning and damning indictment from renowned oncology Professor Angus Dalgleish. He dismantles the entire premise of the COVID-19 vaccine program, revealing a catastrophic failure in scientific understanding and public health policy. His argument, in summary: 1. The Fundamental Flaw: From the start, it was impossible to create an effective vaccine for a coronavirus. Their rapid 3-month mutation wave far outpaces the 6-7 month development of mRNA vaccines. By the time a vaccine is deployed, it targets a virus that is already gone. 2. The "Worse Than Useless" Effect: This is not merely a case of outdated vaccines. It's about "Antigenic Sin" or "Immunological Imprint." The vaccine locks the immune system onto a non-existent version of the virus, using its energy to fight a ghost. This actively impairs the body's ability to recognize and respond to new, real-world variants. 3. The Inconvenient Data: This theory was borne out by real-world evidence. Data began to show that the vaccinated were more likely to get infected by subsequent variants than the unvaccinated. The official response? A circular logic that dismissed the clear signal of harm. 4. The Omicron Blindspot: When Omicron emerged, our health officials saw a disaster. Dalgleish saw "the very best vaccine ever"—a highly infectious, airborne variant that conferred broad immunity with minimal illness. Instead of embracing this natural path to endemicity, they doubled down on boosters, despite evidence linking more jabs to higher infection risk. 5. The Final Betrayal: We now know the foundational claim—that vaccines prevent transmission—was never backed by data. The program continued unabated, creating a cycle of dependency on ineffective shots that potentially worsened population-wide immunity. Professor Dalgleish concludes that the actions of key medical officers amount to "supreme incompetence, if not manipulation against the better interests of the country." A powerful call for accountability and a stark lesson in the dangers of ignoring fundamental immunology.

Camus

59,264 Aufrufe • vor 10 Monaten